Product

Prismocitrate

Aliases

Prismocitrate 18

1 clinical trial

3 indications

Indication

Regional Citrate Anticoagulation

Indication

Continuous Renal Replacement Therapy

Indication

Acute Kidney Injury

Clinical trial

A Safety Evaluation of Prismocitrate 18 in Patients Receiving Continuous Renal Replacement Therapy (CRRT)

Status: Recruiting, Estimated PCD: 2025-09-26